scholarly journals 345P Optimal dose of eribulin as first line treatment in elderly patients ≥ 70 years with advanced breast cancer: A multicenter phase II trial [SAKK 25/14]

2020 ◽  
Vol 31 ◽  
pp. S385
Author(s):  
U. Hasler-Strub ◽  
A. Mueller ◽  
Q. Li ◽  
B.J.K. Thuerlimann ◽  
S. Gerber ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Elderly Patients ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Optimal Dose ◽  
Line Treatment ◽  
First Line ◽  
Multicenter Phase ◽  
First Line Treatment

A phase II trial of paclitaxel (Taxol�) as first line treatment in advanced breast cancer

1995 ◽  
Vol 13 (3) ◽  
pp. 217-222 ◽  
Author(s):  
Sandra M. Swain ◽  
Susan F. Honig ◽  
Mariella C. Tefft ◽  
Linda Walton
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Advanced Breast ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document